Myeloid malignancies: mutations, models and management.

Abstract : ABSTRACT: Myeloid malignant diseases comprise chronic (including myelodysplastic syndromes, myeloproliferative neoplasms and chronic myelomonocytic leukemia) and acute (acute myeloid leukemia) stages. They are clonal diseases arising in hematopoietic stem or progenitor cells. Mutations responsible for these diseases occur in several genes whose encoded proteins belong principally to five classes: signaling pathways proteins (e.g. CBL, FLT3, JAK2, RAS), transcription factors (e.g. CEBPA, ETV6, RUNX1), epigenetic regulators (e.g. ASXL1, DNMT3A, EZH2, IDH1, IDH2, SUZ12, TET2, UTX), tumor suppressors (e.g. TP53), and components of the spliceosome (e.g. SF3B1, SRSF2). Large-scale sequencing efforts will soon lead to the establishment of a comprehensive repertoire of these mutations, allowing for a better definition and classification of myeloid malignancies, the identification of new prognostic markers and therapeutic targets, and the development of novel therapies. Given the importance of epigenetic deregulation in myeloid diseases, the use of drugs targeting epigenetic regulators appears as a most promising therapeutic approach.
Type de document :
Article dans une revue
BMC Cancer, BioMed Central, 2012, 12 (1), pp.304. 〈10.1186/1471-2407-12-304〉
Liste complète des métadonnées

Littérature citée [135 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-00723845
Contributeur : Ed. Bmc <>
Soumis le : mardi 14 août 2012 - 17:03:00
Dernière modification le : mercredi 20 juin 2018 - 11:54:02
Document(s) archivé(s) le : jeudi 15 novembre 2012 - 02:30:29

Fichiers

Identifiants

Collections

Citation

Anne Murati, Mandy Brecqueville, Raynier Devillier, Marie-Joelle Mozziconacci, Véronique Gelsi-Boyer, et al.. Myeloid malignancies: mutations, models and management.. BMC Cancer, BioMed Central, 2012, 12 (1), pp.304. 〈10.1186/1471-2407-12-304〉. 〈inserm-00723845〉

Partager

Métriques

Consultations de la notice

171

Téléchargements de fichiers

287